Outlook Therapeutics, Inc. (OTLK) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 27M |
| Enterprise Value | 49.12M |
| P/E Ratio | -0.41 |
| PEG Ratio | 0 |
| Price/Sales Ratio | -93.24 |
| Price/Book Ratio | -5.86 |
| Enterprise/Revenue | -99.42 |
| Enterprise/EBITDA | -1.86 |
Fiscal Year
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 52.55 |
| Operating Margin | 47.83 |
AD
Management Effectiveness
| Return On Assets | -2.33 |
| Return On Equity | 2.22 |
Income Statement
| Revenue | 1.41M |
| Revenue/Share | -0.01 |
| Gross Profit | 657,205 |
| EBITDA | -63.58M |
| Net Income | -62.42M |
| Diluted EPS | -1.79 |
Balance Sheet
| Total Cash | 11.24M |
| Total Cash/Share | 0.08 |
| Total Debt | 18.43M |
| Total Debt/Equity | -1.77 |
| Current Ratio | 0.81 |
| Book Value Per Share | -0.08 |
Price History
| 52-Week Change | -65.2 |
| 52-Week High | 2.54 |
| 52-Week Low | 0.16 |
| Moving Average 50 Days | 0.57 |
| Moving Average 200 Days | 0.66 |
Statistics
| Average Volume | 9.57M |
| Shares Outstanding | 243.45M |
| % Held by Institutions | 79.54 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | March 14, 2024 |
AD
